Syntara Limited (ASX:SNT)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Medicines for Blood Cancers and Conditions Linked to Inflammation and Fibrosis	7.30M	5.76M	6.23M	5.68M	544.00K
Mannitol Respiratory Business	-	-	-	9.77M	22.67M
Corporate	-	-	-	308.00K	416.00K
Total	7.30M	5.76M	6.23M	15.76M	23.63M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Australia	917.00K	1.41M
Western Europe	790.00K	813.00K
Europe	770.00K	564.00K
USA & Canada	334.00K	98.00K
South Korea	267.00K	350.00K
Central and Eastern Europe	506.00K	636.00K
Russia	2.23M	1.37M
United States	1.62M	1.45M
Total	7.43M	6.68M

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error